本文選題：神經(jīng)內(nèi)分泌癌　切入點(diǎn)：影像學(xué)　出處：《臨床放射學(xué)雜志》2017年04期

【摘要】：目的觀察全身少見(jiàn)部位神經(jīng)內(nèi)分泌癌的CT與MRI表現(xiàn),提高對(duì)其認(rèn)識(shí)。方法回顧性分析經(jīng)病理證實(shí)的18例神經(jīng)內(nèi)分泌癌患者的臨床及CT與MRI資料。8例行CT檢查,其中4例行CT增強(qiáng)掃描;17例行MRI檢查,其中13例行動(dòng)態(tài)增強(qiáng)掃描。結(jié)果位于鼻腔鼻竇7例,子宮6例,卵巢1例,乳腺3例,腎臟1例。11例邊界清晰,7例邊界欠清。CT表現(xiàn):軟組織密度影,病變周圍明顯骨質(zhì)破壞及轉(zhuǎn)移灶,增強(qiáng)掃描病灶呈中等程度強(qiáng)化。MRI表現(xiàn):7例呈長(zhǎng)T_1、長(zhǎng)T_2信號(hào),3例呈等T_1、稍長(zhǎng)T_2,3例呈稍長(zhǎng)T_1、混雜長(zhǎng)T_2信號(hào),1例呈等T_1、等T_2信號(hào),3例子宮頸內(nèi)膜不均勻增厚未見(jiàn)明顯異常信號(hào)。4例DWI高b值彌散受限呈稍高信號(hào),11例彌散受限呈高信號(hào),2例未見(jiàn)明顯受限,平均ADC值為(0.64±0.12)×10~(-3)mm~2/s。增強(qiáng)掃描可見(jiàn)病變呈中等程度強(qiáng)化。時(shí)間-信號(hào)強(qiáng)度曲線:流入型2例,平臺(tái)型3例,流出型8例。結(jié)論少見(jiàn)部位神經(jīng)內(nèi)分泌癌CT與MRI具有一定特征性改變,CT結(jié)合MRI檢查可明確病變的范圍及有無(wú)轉(zhuǎn)移,通過(guò)MRI動(dòng)態(tài)增強(qiáng)可以了解病變的血供情況,有利于明確診斷并協(xié)助臨床醫(yī)師制定治療方案。
[Abstract]:Objective to observe CT and MRI findings of neuroendocrine carcinoma in rare part of the body.Methods the clinical features and CT and MRI findings of 18 patients with neuroendocrine carcinoma confirmed by pathology were retrospectively analyzed. Ct enhanced CT scan was performed in 17 patients and dynamic enhanced CT scan was performed in 13 patients.Results there were 7 cases located in nasal cavity and sinuses, 6 cases in uterus, 1 case in ovary, 3 cases in mammary gland, 1 case in kidney, 1 case in clear boundary and 7 cases with unclear boundary. Ct findings showed soft tissue density, obvious bone destruction and metastasis around the lesion.澧炲己鎵弿鐥呯伓鍛堜腑絳夌▼搴﹀己鍖，

本文編號(hào)：1710413